NCT01477372

Brief Summary

The purpose of this study was to assess the effectiveness of a moderated physical exercise program called Blooming Exercise Program (BEP) developed during pregnancy in order to control excessive maternal weight gain and its consequences. Additionally, other objectives of the study were to analyse the influence of BEP on urinary incontinence, on the other pregnancy outcomes and on the perception of the pregnant's health

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
320

participants targeted

Target at P75+ for not_applicable pregnancy

Timeline
Completed

Started Sep 2007

Typical duration for not_applicable pregnancy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2011

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 22, 2011

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 22, 2011

Completed
Last Updated

April 11, 2012

Status Verified

April 1, 2012

Enrollment Period

3.4 years

First QC Date

September 22, 2011

Last Update Submit

April 10, 2012

Conditions

Keywords

PregnancyExerciseExcessive weight gainOutcomesUrinary incontinence

Outcome Measures

Primary Outcomes (1)

  • Maternal weight gain

    Maternal weight gain and proportion of participants exceeding weight gain above IOM (2009) recommendations

    week 36-38 of gestation

Secondary Outcomes (3)

  • Excessive weight gain related risks (gestational diabetes, macrosomia, type of delivery)

    week 36-38 of gestation

  • Urinary incontinence

    week 36-38 of gestation

  • Other pregnancy outcomes (maternal and foetal)

    week 36-38 of gestation

Study Arms (2)

Exercise group

EXPERIMENTAL

Supervised exercise program

Behavioral: Supervised exercise program

Control

NO INTERVENTION

Sedentary pregnant woman

Interventions

Intervention group participated in Blooming Exercise Program as from week 10-12 of gestation. At least 56 sessions through 22 weeks. 3 sessions per week

Exercise group

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy pregnant women
  • Delivering in "Hospital Universitario de Fuenlabrada"
  • At week 10-14 of gestation
  • Able to attend 3 sessions per week until the end of the pregnancy

You may not qualify if:

  • Contraindications appointed by ACOG
  • Less than 56 sessions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitarian Hospital of Fuenlabrada

Fuenlabrada, Madrid, 28942, Spain

Location

Related Publications (1)

  • Pelaez M, Gonzalez-Cerron S, Montejo R, Barakat R. Protective Effect of Exercise in Pregnant Women Including Those Who Exceed Weight Gain Recommendations: A Randomized Controlled Trial. Mayo Clin Proc. 2019 Oct;94(10):1951-1959. doi: 10.1016/j.mayocp.2019.01.050.

MeSH Terms

Conditions

Motor ActivityUrinary Incontinence

Condition Hierarchy (Ancestors)

BehaviorUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ruben O Barakat, PhD

    Universidad Politecnica de Madrid

    STUDY DIRECTOR
  • Mireia Peláez, PhD

    Universidad Politecnica de Madrid

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

September 22, 2011

First Posted

November 22, 2011

Study Start

September 1, 2007

Primary Completion

February 1, 2011

Study Completion

February 1, 2011

Last Updated

April 11, 2012

Record last verified: 2012-04

Locations